May. 15 at 2:14 PM
PBH delivered a strong 4QFY25, beating on both revenue and EPS, with broad-based growth and record free cash flow performance.
🔹 Adjusted EPS of
$1.32 beat consensus and rose 29% Y/Y
🔹 Revenue grew 7% to
$296.5M, driven by strong North America performance in women’s health and GI
🔹 E-commerce growth surged, aided by ~
$7M in pre-tariff buying
🔹 EBITDA margin expanded 260bps to 35.2%, with
$243.9M in FY25 free cash flow
🔹 Leverage ratio dropped to 2.4x; management building cash for future acquisitions or potential buybacks
Prestige Consumer Healthcare strong execution and financial discipline set the stage for continued value creation in FY26.
https://www.watertowerresearch.com/doc?docID=UR_PBH_05142025
$PBH #Earnings #ConsumerHealth #SmallCapSpotlight #HealthcareStocks #GrowthStrategy #FreeCashFlow #Investing #WTRInsights
